Regardless of the pathway in which c-MET is activated, dimerization, phosphorylation, and kinase activation are necessary for malignant lesions in neurogenic tumors.[6] c-MET was highly expressed in GBM cells, blood vessels, and peri-necrotic areas. Here, MET is linked to glioblastoma.